Infectious Diseases Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition: HIV/AIDS Interventions: Behavioral: Healthy Living Intervention (HLI); Behavioral: Standard of Care Sponsors: University of California, San Francisco; University of California, Berkeley; Makerere University; Infectious Diseases Research Collaboration, Uganda; Kenya Medical Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Evaluation of The Food Allergy Mastery Program
Condition: Food Allergy in Children Intervention: Behavioral: Food Allergy Mastery Program Sponsors: Children's National Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); Northwestern University; Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Evaluation of The Food Allergy Mastery Program
Condition: Food Allergy in Children Intervention: Behavioral: Food Allergy Mastery Program Sponsors: Children's National Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); Northwestern University; Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition: HIV/AIDS Interventions: Behavioral: Healthy Living Intervention (HLI); Behavioral: Standard of Care Sponsors: University of California, San Francisco; University of California, Berkeley; Makerere University; Infectious Diseases Research Collaboration, Uganda; Kenya Medical Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2)
Condition: Pneumonia Childhood Intervention: Behavioral: Clinical Decision Support Sponsors: Vanderbilt University Medical Center; National Institute of Allergy and Infectious Diseases (NIAID); University of Pittsburgh Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Evaluation of The Food Allergy Mastery Program
Condition: Food Allergy in Children Intervention: Behavioral: Food Allergy Mastery Program Sponsors: Children's National Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); Northwestern University; Rhode Island Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)
Condition: HIV/AIDS Interventions: Behavioral: Healthy Living Intervention (HLI); Behavioral: Standard of Care Sponsors: University of California, San Francisco; University of California, Berkeley; Makerere University; Infectious Diseases Research Collaboration, Uganda; Kenya Medical Research Institute; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition: HIV Interventions: Biological: N332-GT5 gp140 (IM, Bolus); Biological: N332-GT5 gp140 (IM, Fractioned); Biological: N332-GT5 gp140 (SC, Bolus); Biological: N332-GT5 gp140 (SC, Fractioned); Biological: SMNP (IM, Bolus); Biological: SMNP (IM, Fractioned); Biological: SMNP (S C, Bolus); Biological: SMNP (SC, Fractioned) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Tocilizumab in Lung Transplantation
Condition: Lung Transplant Interventions: Drug: Tocilizumab; Drug: Placebo for Tocilizumab Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials